Hepapar
NDC 44911-0719, Carduus Marianus, Chelidonium Majus, Lappa Major, Taraxacum Officinale, Boldo, Cholinum, Hepar Suis, Lycopodium Clavatum, Mercurius Solubilis, Natrum Sulphuricum, Nux Vomica, Phosphorus, Quercus Glandium Spiritus, Aurum Muriaticum Natronatum, Chenopodium Anthelminticum, liquid, from Energique, Inc..
- Product NDC
- 44911-0719
- Status
- Listed
- Labeler
- Energique, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0719 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MILK THISTLE3 [hp_X]/mL
- CHELIDONIUM MAJUS WHOLE3 [hp_X]/mL
- ARCTIUM LAPPA ROOT3 [hp_X]/mL
- TARAXACUM OFFICINALE3 [hp_X]/mL
- PEUMUS BOLDUS LEAF6 [hp_X]/mL
- CHOLINE HYDROXIDE6 [hp_X]/mL
- PORK LIVER6 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE12 [hp_X]/mL
- MERCURIUS SOLUBILIS12 [hp_X]/mL
- SODIUM SULFATE12 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED12 [hp_X]/mL
- PHOSPHORUS12 [hp_X]/mL
- QUERCUS ROBUR NUT12 [hp_X]/mL
- SODIUM TETRACHLOROAURATE16 [hp_X]/mL
- DYSPHANIA AMBROSIOIDES WHOLE16 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 44911-0719-1 | 44911071901 | 30 mL in 1 BOTTLE, DROPPER (44911-0719-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 44911-0719 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0719 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 44911-0719. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.